Education
About Us
Working with TipRanks
Follow Us
Chemours Company (CC)
NYSE:CC
CC Analyst Ratings
Moderate Buy
6 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CC Stock 12 Month Forecast
Average Price Target
$14.88
▲(5.91%Upside)
| Highest Price Target$20.00 | Average Price Target$14.88 | Lowest Price Target$11.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$14
Hold
-0.36%
Downside
Reiterated
07/09/25
Chemours Company's overall stock score reflects significant financial challenges, including high leverage and cash flow issues. While technical indicators suggest some positive momentum, potential overvaluation and strategic shifts, notably the dividend reduction, weigh on the stock's attractiveness. Strong performance in certain segments and strategic agreements offer some positive outlook amidst the challenges.
RBC Capital
$14→$15
Buy
6.76%
Upside
Reiterated
07/03/25
UBS
$17
Buy
21.00%
Upside
Reiterated
07/01/25
Morgan Stanley
$15
Hold
6.76%
Upside
Reiterated
06/23/25
BMO Capital
$17
Buy
21.00%
Upside
Reiterated
06/18/25
Truist Financial
$20
Buy
42.35%
Upside
Reiterated
06/18/25
Alembic Global
$18
Buy
28.11%
Upside
Reiterated
06/02/25
CC shares are also rated Overweight with a 12‐month TP of USD18.
Barclays
$16→$13
Hold
-7.47%
Downside
Reiterated
05/28/25
Goldman Sachs
$21→$14
Hold
-0.36%
Downside
Reiterated
05/14/25
J.P. Morgan
$18→$13
Hold
-7.47%
Downside
Reiterated
05/13/25
Jefferies
$20→$11.5
Hold
-18.15%
Downside
Reiterated
05/08/25
Mizuho Securities
$15→$13
Buy
-7.47%
Downside
Reiterated
05/07/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$14
Hold
-0.36%
Downside
Reiterated
07/09/25
Chemours Company's overall stock score reflects significant financial challenges, including high leverage and cash flow issues. While technical indicators suggest some positive momentum, potential overvaluation and strategic shifts, notably the dividend reduction, weigh on the stock's attractiveness. Strong performance in certain segments and strategic agreements offer some positive outlook amidst the challenges.
RBC Capital
$14→$15
Buy
6.76%
Upside
Reiterated
07/03/25
UBS
$17
Buy
21.00%
Upside
Reiterated
07/01/25
Morgan Stanley
$15
Hold
6.76%
Upside
Reiterated
06/23/25
BMO Capital
$17
Buy
21.00%
Upside
Reiterated
06/18/25
Truist Financial
$20
Buy
42.35%
Upside
Reiterated
06/18/25
Alembic Global
$18
Buy
28.11%
Upside
Reiterated
06/02/25
CC shares are also rated Overweight with a 12‐month TP of USD18.
Barclays
$16→$13
Hold
-7.47%
Downside
Reiterated
05/28/25
Goldman Sachs
$21→$14
Hold
-0.36%
Downside
Reiterated
05/14/25
J.P. Morgan
$18→$13
Hold
-7.47%
Downside
Reiterated
05/13/25
Jefferies
$20→$11.5
Hold
-18.15%
Downside
Reiterated
05/08/25
Mizuho Securities
$15→$13
Buy
-7.47%
Downside
Reiterated
05/07/25
Best Analysts Covering Chemours Company
1 Month
xxx
Success Rate
12/21 ratings generated profit
Average Return
+3.52%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of +3.52% per trade.
3 Months
xxx
Success Rate
12/21 ratings generated profit
Average Return
+6.09%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +6.09% per trade.
1 Year
Success Rate
11/21 ratings generated profit
Average Return
+1.29%
reiterated a buy rating last month
Copying Hassan Ahmed's trades and holding each position for 1 Year would result in 52.38% of your transactions generating a profit, with an average return of +1.29% per trade.
2 Years
xxx
Success Rate
10/24 ratings generated profit
Average Return
-12.07%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of -12.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CC Analyst Recommendation Trends
Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
6
8
9
9
6
Buy
5
4
7
6
6
Hold
10
8
8
9
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
20
24
24
20
Each month's total comprises the sum of three months' worth of ratings.
CC Financial Forecast
CC Stock Forecast FAQ
What is CC’s average 12-month price target, according to analysts?
Based on analyst ratings, Chemours Company’s 12-month average price target is 14.88.
What is CC’s upside potential, based on the analysts’ average price target?
Chemours Company has 5.91% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CC a Buy, Sell or Hold?
Chemours Company has a consensus rating of Moderate Buy which is based on 6 buy ratings, 6 hold ratings and 0 sell ratings.
What is Chemours Company’s price target?
The average price target for Chemours Company is 14.88. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $11.50. The average price target represents 5.91% Increase from the current price of $14.05.
The highest analyst price target is $20.00 ,the lowest forecast is $11.50. The average price target represents 5.91% Increase from the current price of $14.05.
What do analysts say about Chemours Company?
Chemours Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of CC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.